SOUTH SAN FRANCISCO, Calif., Jan. 15, 2016 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA) today announced the appointment of Kelly Bryant as senior director, business development based in CLSA's South San Francisco office. Bryant is responsible for designing and delivering the best in class member experience that CLSA members have come to expect. Bryant will spearhead member development programs and serves as the Bay Area's trusted resource for maximizing CLSA's membership privileges. As the nation's largest statewide life sciences public policy, advocacy and business solutions organization, CLSA serves over 750 life sciences organizations across California.
Bryant will play a key role in business development and forging partnerships throughout the state, while implementing strategic programs that produce premium member value. Additionally, Bryant will serve as an ambassador for CLSA, building industry wide awareness of the CLSA member experience.
"As CLSA continues to grow and support California's life sciences economy and community, we sought an industry veteran to help meet and exceed the member goals and business objectives of our organization," said CLSA President and CEO Sara Radcliffe. "Given Kelly's extensive background and leadership qualities, CLSA members will greatly benefit from this dynamic asset."
Bryant's track record spans from the medical device, technical genomic and health sciences sectors including stints at Ceres, MDVIP (a Proctor & Gamble Co.), and Boston Scientific.
"Kelly embodies exactly what CLSA members expect when they join the most prestigious network of life sciences pioneers, risk takers and thought leaders," said Holly Smithson, Senior Vice President, Business Strategy and Development. "Kelly is a dynamic professional and committed to brokering member successes at all levels. I expect CLSA members may well enjoy her X factor."
Headshot available upon request.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Contact:
Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



